Veru is developing enobosarm for weight loss management and announced a collaboration with Laxxon Medical regarding the formulation.
3 reports, 3 independent
Updated Aug 15
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Veru is developing enobosarm for weight loss management and announced a collaboration with Laxxon Medical regarding the formulation.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Veru collaborates with Laxxon Medical on enobosarm formulation for weight loss.1 source
Laxxon Medical, led by Helmut Kerschbaumer, will use SPID technology for enobosarm formulation.1 source
Keep exploring
The entities involved
-
SARM
Japanese singer-songwriter
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksVeru Announces Novel Modified-Release Oral Formulation for Enobosarm Veru Inc. VERU recently announced the selection of a novel modified-release oral formulation for enobosarm for chronic weight loss
- Business WireLaxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru’s Enobosarm, Utilizing Laxxon’s SPID®-Technology NEW YORK, August 11, 2025--(BUS
- GlobeNewswireVeru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru